Europe Head & Neck Cancer Market and Competitive Landscape – 2017
The latest research from Fore Pharma, Europe Head & Neck Cancer Market and Competitive Landscape – 2017, provides comprehensive insights into Head & Neck Cancer pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Head & Neck Cancer market size and drug sales. This research also provides insights into Head & Neck Cancer epidemiology and late stage pipeline.
The report is classified into nine sections – Head & Neck Cancer overview with definitions, symptoms, etiology, diagnosis, treatment options; Head & Neck Cancer pipeline insights covering late stage clinical trials pipeline; Head & Neck Cancer prevalence trends by countries; Head & Neck Cancer market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries – Germany, France, Italy, Spain, UK, Europe.
Research Scope:
- Head & Neck Cancer pipeline: Find out the drugs in clinical trials for Head & Neck Cancer by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
- Head & Neck Cancer epidemiology: Find out the prevalence of Head & Neck Cancer by countries – Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
- Head & Neck Cancer products: Identify key products marketed and prescribed for Head & Neck Cancer by brand name, by molecule, by company, by branded / generic, by countries – Europe, Germany, France, Italy, Spain, UK, Japan
- Head & Neck Cancer market size: Find out the market size for Head & Neck Cancer drugs by countries – Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
- Head & Neck Cancer drug sales: Find out the sales of Head & Neck Cancer drugs by countries – Europe, Germany, France, Italy, Spain, UK
- Head & Neck Cancer drugs sales forecast: Sales forecast for Head & Neck Cancer drugs to 2021 by countries – Europe, Germany, France, Italy, Spain, UK, Japan
- Head & Neck Cancer market share analysis: Find out the market shares of Head & Neck Cancer drugs and outlook by countries – Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
- Evaluate commercial market opportunities for Head & Neck Cancer drugs
- Synthesize insights for business development & licensing
- Track market size, competitor drug sales, market shares in Head & Neck Cancer market
- Develop in-depth knowledge of competition and markets
- Analyze sales data to update your brand planning trackers
- Develop tactics and strategies to take advantage of opportunities in the market
- Track market trends and analyze key events in Head & Neck Cancer market
- Develop forecast models, healthcare frameworks, or economic models
- Answer key business questions; supports decision making in R&D to long term marketing strategies
- 1. Head & Neck Cancer: Disease Overview
- 1.1. Head & Neck Cancer Symptoms
- 1.2. Head & Neck Cancer Etiology
- 1.3. Head & Neck Cancer Diagnosis
- 1.4. Head & Neck Cancer Treatment Options
- 2. Head & Neck Cancer Pipeline Insights
- 2.1. Head & Neck Cancer Phase 3 Clinical Trials
- 2.2. Head & Neck Cancer Phase 2 Clinical Trials
- 2.3. Head & Neck Cancer Phase 1 Clinical Trials
- 3. Head & Neck Cancer Epidemiology Analysis
- 4. Germany Head & Neck Cancer Market Insights
- 4.1. Marketed Products for Head & Neck Cancer in Germany
- 4.2. Germany Head & Neck Cancer Market Size & Forecast
- 4.3. Germany Head & Neck Cancer Product Sales Forecast
- 4.4. Germany Head & Neck Cancer Market Share Analysis
- 5. France Head & Neck Cancer Market Insights
- 5.1. Marketed Products for Head & Neck Cancer in France
- 5.2. France Head & Neck Cancer Market Size & Forecast
- 5.3. France Head & Neck Cancer Product Sales Forecast
- 5.4. France Head & Neck Cancer Market Share Analysis
- 6. Italy Head & Neck Cancer Market Insights
- 6.1. Marketed Products for Head & Neck Cancer in Italy
- 6.2. Italy Head & Neck Cancer Market Size & Forecast
- 6.3. Italy Head & Neck Cancer Product Sales Forecast
- 6.4. Italy Head & Neck Cancer Market Share Analysis
- 7. Spain Head & Neck Cancer Market Insights
- 7.1. Marketed Products for Head & Neck Cancer in Spain
- 7.2. Spain Head & Neck Cancer Market Size & Forecast
- 7.3. Spain Head & Neck Cancer Product Sales Forecast
- 7.4. Spain Head & Neck Cancer Market Share Analysis
- 8. UK Head & Neck Cancer Market Insights
- 8.1. Marketed Products for Head & Neck Cancer in UK
- 8.2. UK Head & Neck Cancer Market Size & Forecast
- 8.3. UK Head & Neck Cancer Product Sales Forecast
- 8.4. UK Head & Neck Cancer Market Share Analysis
- 9. Europe Head & Neck Cancer Market Insights
- 9.1. Europe Head & Neck Cancer Market Size & Forecast
- 9.2. Europe Head & Neck Cancer Product Sales Forecast
- 9.3. Europe Head & Neck Cancer Market Share Analysis
- 10. Research Methodology
- LIST OF TABLES
- Table 1: Head & Neck Cancer Phase 3 Clinical Trials, Global, 2017
- Table 2: Head & Neck Cancer Phase 2 Clinical Trials, Global, 2017
- Table 3: Head & Neck Cancer Phase 1 Clinical Trials, Global, 2017
- Table 4: Head & Neck Cancer Prevalence by EU5 Countries, 2012 - 2021
- Table 5: Marketed Products for Head & Neck Cancer in Germany, 2017
- Table 6: Germany Head & Neck Cancer Market Size & Forecast ($mn), 2012 - 2021
- Table 7: Germany Head & Neck Cancer Product Sales ($mn), 2012 - 2021
- Table 8: Germany Head & Neck Cancer Market Trends, 2012 - 2021
- Table 9: Marketed Products for Head & Neck Cancer in France, 2017
- Table 10: France Head & Neck Cancer Market Size & Forecast ($mn), 2012 - 2021
- Table 11: France Head & Neck Cancer Product Sales ($mn), 2012 - 2021
- Table 12: France Head & Neck Cancer Market Trends, 2012 - 2021
- Table 13: Marketed Products for Head & Neck Cancer in Italy, 2017
- Table 14: Italy Head & Neck Cancer Market Size & Forecast ($mn), 2012 - 2021
- Table 15: Italy Head & Neck Cancer Product Sales ($mn), 2012 - 2021
- Table 16: Italy Head & Neck Cancer Market Trends, 2012 - 2021
- Table 17: Marketed Products for Head & Neck Cancer in Spain, 2017
- Table 18: Spain Head & Neck Cancer Market Size & Forecast ($mn), 2012 - 2021
- Table 19: Spain Head & Neck Cancer Product Sales ($mn), 2012 - 2021
- Table 20: Spain Head & Neck Cancer Market Trends, 2012 - 2021
- Table 21: Marketed Products for Head & Neck Cancer in UK, 2017
- Table 22: UK Head & Neck Cancer Market Size & Forecast ($mn), 2012 - 2021
- Table 23: UK Head & Neck Cancer Product Sales ($mn), 2012 - 2021
- Table 24: UK Head & Neck Cancer Market Trends, 2012 - 2021
- Table 25: Europe Head & Neck Cancer Market Size & Forecast ($mn), 2012 - 2021
- Table 26: Europe Head & Neck Cancer Product Sales ($mn), 2012 - 2021
- LIST OF FIGURES
- Figure 1: Head & Neck Cancer Pipeline by Phase (%), Global, 2017
- Figure 2: Head & Neck Cancer Prevalence by EU5 Countries, 2012 - 2021
- Figure 3: Germany Head & Neck Cancer Market Size ($mn), 2012 - 2021
- Figure 4: Germany Head & Neck Cancer Product Sales ($mn), 2012 - 2021
- Figure 5: Germany Head & Neck Cancer Market Share by Products (%), 2016
- Figure 6: Germany Head & Neck Cancer Market - Future Market Share (%), 2021
- Figure 7: France Head & Neck Cancer Market Size ($mn), 2012 - 2021
- Figure 8: France Head & Neck Cancer Product Sales ($mn), 2012 - 2021
- Figure 9: France Head & Neck Cancer Market Share by Products (%), 2016
- Figure 10: France Head & Neck Cancer Market - Future Market Share (%), 2021
- Figure 11: Italy Head & Neck Cancer Market Size ($mn), 2012 - 2021
- Figure 12: Italy Head & Neck Cancer Product Sales ($mn), 2012 - 2021
- Figure 13: Italy Head & Neck Cancer Market Share by Products (%), 2016
- Figure 14: Italy Head & Neck Cancer Market - Future Market Share (%), 2021
- Figure 15: Spain Head & Neck Cancer Market Size ($mn), 2012 - 2021
- Figure 16: Spain Head & Neck Cancer Product Sales ($mn), 2012 - 2021
- Figure 17: Spain Head & Neck Cancer Market Share by Products (%), 2016
- Figure 18: Spain Head & Neck Cancer Market - Future Market Share (%), 2021
- Figure 19: UK Head & Neck Cancer Market Size ($mn), 2012 - 2021
- Figure 20: UK Head & Neck Cancer Product Sales ($mn), 2012 - 2021
- Figure 21: UK Head & Neck Cancer Market Share by Products (%), 2016
- Figure 22: UK Head & Neck Cancer Market - Future Market Share (%), 2021
- Figure 23: Europe Head & Neck Cancer Market Size ($mn), 2012 - 2021
- Figure 24: Europe Head & Neck Cancer Product Sales ($mn), 2012 - 2021
- Figure 25: Europe Head & Neck Cancer Market Share by Products (%), 2016
- Figure 26: Europe Head & Neck Cancer Market - Future Market Share (%), 2021